0001209191-18-048513.txt : 20180827
0001209191-18-048513.hdr.sgml : 20180827
20180827170322
ACCESSION NUMBER: 0001209191-18-048513
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180823
FILED AS OF DATE: 20180827
DATE AS OF CHANGE: 20180827
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sutton Gregg S
CENTRAL INDEX KEY: 0001304052
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23837
FILM NUMBER: 181039484
MAIL ADDRESS:
STREET 1: 6464 SYCAMORE COURT NORTH
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55369
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SURMODICS INC
CENTRAL INDEX KEY: 0000924717
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 411356149
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 9924 W 74TH ST
CITY: EDEN PRAIRIE
STATE: MN
ZIP: 55344
BUSINESS PHONE: 9525007000
MAIL ADDRESS:
STREET 1: 9924 WEST 74TH ST
CITY: EDEN PRAIRIE
STATE: MN
ZIP: 55344
FORMER COMPANY:
FORMER CONFORMED NAME: BSI CORP
DATE OF NAME CHANGE: 19970506
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-08-23
0
0000924717
SURMODICS INC
SRDX
0001304052
Sutton Gregg S
9924 WEST 74TH STREET
EDEN PRAIRIE
MN
55344
0
1
0
0
VP of Research and Development
Common Stock
2018-08-23
4
M
0
10544
19.42
A
19853
D
Common Stock
2018-08-23
4
M
0
4280
23.95
A
24133
D
Common Stock
2018-08-23
4
S
0
14204
74.1079
D
9929
D
Common Stock
2018-08-23
4
S
0
620
74.9419
D
9309
D
Employee Stock Option (right to buy)
19.42
2018-08-23
4
M
0
10544
0.00
D
2023-02-16
Common Stock
10544
10544
D
Employee Stock Option (right to buy)
23.95
2018-08-23
4
M
0
4280
0.00
D
2023-11-30
Common Stock
4280
12841
D
Includes 497 shares acquired through the Employee Stock Purchase Plan for the phase ending in February 2018.
Reflects the weighted average price of 14,204 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on August 23, 2018 with sale prices ranging from $73.80 to $74.75 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Reflects the weighted average price of 620 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on August 23, 2018 with sale prices ranging from $74.825 to $75.05 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
The award vests in four equal installments on each of the first four anniversaries of the February 16, 2016 grant date.
The award vests in four equal installments on each of the first four anniversaries of the November 30, 2016 grant date.
/s/ Bryan K. Phillips, attorney-in-fact for Gregg S. Sutton
2018-08-27